IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1

Historical Holders from Q4 2020 to Q4 2024

Type / Class
Debt / NOTE 0.125%12/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2024 Q4 $0 $0 -$41,412,833 0
2024 Q3 $42,082,000 $41,432,496 -$2,528,267 98.33% 18
2024 Q2 $44,651,000 $43,150,120 +$1,968,865 98.06% 16
2024 Q1 $42,911,000 $40,606,333 -$2,036,900 94.41% 17
2023 Q4 $45,100,000 $43,062,073 +$496,490 95.69% 16
2023 Q3 $44,639,000 $42,503,289 -$63,789,292 95.13% 15
2023 Q2 $113,009,000 $105,739,050 -$374,542,371 93.5% 27
2023 Q1 $517,348,516 $478,765,818 -$23,007,437 92.51% 42
2022 Q4 $542,898,250 $494,915,958 +$24,259,284 90.91% 46
2022 Q3 $471,768,498 $430,631,048 -$2,821,229 90.93% 44
2022 Q2 $470,326,998 $421,150,350 -$33,768,136 87.98% 41
2022 Q1 $514,547,508 $466,687,900 +$10,040,765 90.0% 40
2021 Q4 $503,537,704 $453,953,373 -$3,795,397 90.03% 40
2021 Q3 $517,267,606 $476,967,352 -$541,267 91.69% 48
2021 Q2 $512,971,856 $476,527,327 -$26,423,228 92.92% 43
2021 Q1 $541,120,833 $516,289,488 -$13,969,065 95.54% 44
2020 Q4 $554,277,000 $571,053,677 +$566,549,000 102.5% 35